Amooru Gangaiah Damu (Damu Gangaiah Amooru, Damu Amooru Gangaiah)
Publication Activity (10 Years)
Years Active: 2017-2024
Publications (10 Years): 8
Publications (10 Years): 8
Publications
- Kandrakonda Yelamanda Rao, Remya Chandran, K V Dileep, Sri Charitha Gorantla, Shaik Jeelan Basha, Sreelakshmi Mothukuru, Irla Siva Kumar, Katta Vamsi, Sandeep Kumar, Aramati Bindu Madhava Reddy, Rajagopal Subramanyam, Amooru Gangaiah Damu
- Murali Vatturu, Kandrakonda Yelamanda Rao, Valaparla Bala Yesu, Shaik Jeelan Basha, Tanguturi Prakash Guptha, Donka Suresh Babu, Kethineni Sajitha, Gundlapalli Pavan Kalyan, Amooru Gangaiah Damu, Doddaga Srinivasulu
- Murali Vatturu, Kandrakonda Yelamanda Rao, Valaparla Bala Yesu, Shaik Jeelan Basha, Tanguturi Prakash Guptha, Donka Suresh Babu, Kethineni Sajitha, Gundlapalli Pavan Kalyan, Amooru Gangaiah Damu, Doddaga Srinivasulu
- Murali Vatturu, Kandrakonda Yelamanda Rao, Valaparla Bala Yesu, Shaik Jeelan Basha, Tanguturi Prakash Guptha, Donka Suresh Babu, Kethineni Sajitha, Gundlapalli Pavan Kalyan, Amooru Gangaiah Damu, Doddaga Srinivasulu
- Murali Vatturu, Kandrakonda Yelamanda Rao, Valaparla Bala Yesu, Shaik Jeelan Basha, Tanguturi Prakash Guptha, Donka Suresh Babu, Kethineni Sajitha, Gundlapalli Pavan Kalyan, Amooru Gangaiah Damu, Doddaga Srinivasulu
- Mohan Penumala, Raveendra Babu Zinka, Jeelan Basha Shaik, Suresh Kumar Reddy Mallepalli, Ramakrishna Vadde, Amooru Gangaiah Damu
- Shaik Jeelan Basha, Penumala Mohan, Daniel Pushparaju Yeggoni, Zinka Raveendra Babu, Palaka Bhagath Kumar, Ampasala Dinakara Rao, Rajagopal Subramanyam, Amooru Gangaiah DamuNew Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of β-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase. Molecular pharmaceutics 15 (6) (2018)
- Mohan Penumala, Raveendra Babu Zinka, Jeelan Basha Shaik, Amooru Gangaiah Damu